Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI).
D000047:Academies and Institutes; D000700:Analgesics / Q000494:pharmacology*; D000704:Analysis of Variance; D001007:Anxiety; D001392:Azocines / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003496:Cyclazocine / Q000009:adverse effects / Q000494:pharmacology; D004644:Emotions / Q000187:drug effects*; D005059:Euphoria; D006309:Hearing / Q000187:drug effects; D006782:Hospitals, Special; D006791:Hostility / Q000187:drug effects; D006801:Humans; D007398:Interpersonal Relations; D007629:Kentucky; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009068:Movement / Q000187:drug effects; D009269:Nalorphine / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009316:National Institutes of Health (U.S.); D010424:Pentobarbital / Q000494:pharmacology; D010465:Perception / Q000187:drug effects*; D010919:Placebos; D011340:Problem Solving / Q000187:drug effects; D012106:Research; D012677:Sensation / Q000187:drug effects*; D019966:Substance-Related Disorders; D013649:Taste / Q000187:drug effects; D013998:Time Perception / Q000187:drug effects; D014110:Touch / Q000187:drug effects; D014481:United States
D000700:Analgesics; D001392:Azocines; D009292:Narcotic Antagonists; D010919:Placebos; D009020:Morphine; D008238:Lysergic Acid Diethylamide; D010424:Pentobarbital; D003496:Cyclazocine; D009269:Nalorphine